Literature DB >> 33362850

Reporting Genetic Findings to Individual Research Participants: Guidelines From the Swiss Personalized Health Network.

Alessandro Blasimme1, Caroline Brall1,2, Effy Vayena1,2.   

Abstract

In 2017 the Swiss federal government established the Swiss Personalized Health Network (SPHN), a nationally coordinated data infrastructure for genetic research. The SPHN advisory group on Ethical, Legal, and Social Implications (ELSI) was tasked with the creation of a recommendation to ensure ethically responsible reporting of genetic research findings to research participants in SPHN-funded studies. Following consultations with expert stakeholders, including geneticists, pediatricians, sociologists, university hospitals directors, patient representatives, consumer protection associations, and insurers, the ELSI advisory group issued its recommendation on "Reporting actionable genetic findings to research participants" in May 2020. In this paper we outline the development of this recommendation and the provisions it contains. In particular, we discuss some of its key features, namely: (1) that participation in SPHN-funded studies as a research subject is conditional to accepting that medically relevant genetic research findings will be reported; (2) that a Multidisciplinary Expert Panel (MEP) should be created to support researchers' decision-making processes about reporting individual genetic research findings; (3) that such Multidisciplinary Expert Panel will make case-by-case decisions about whether to allow reporting of genetic findings, instead of relying on a pre-defined list of medically relevant variants; (4) that research participants shall be informed of the need to disclose genetic mutations when applying for private insurance, which may influence individual decisions about participation in research. By providing an account of the procedural background and considerations leading to the SPHN recommendation on "Reporting actionable genetic findings to research participants," we seek to promote a better understanding of the proposed guidance, as well as to contribute to the global dialog on the reporting of genetic research findings.
Copyright © 2020 Blasimme, Brall and Vayena.

Entities:  

Keywords:  Switzerland; ethical recommendations; expert stakeholder consultation; genetic research findings; reporting; return of results

Year:  2020        PMID: 33362850      PMCID: PMC7759560          DOI: 10.3389/fgene.2020.585820

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  30 in total

Review 1.  The personal and clinical utility of polygenic risk scores.

Authors:  Ali Torkamani; Nathan E Wineinger; Eric J Topol
Journal:  Nat Rev Genet       Date:  2018-09       Impact factor: 53.242

2.  AMA Code of Medical Ethics Available Online.

Authors:  H Rakatansky
Journal:  Virtual Mentor       Date:  2001-04-01

3.  Actionable, pathogenic incidental findings in 1,000 participants' exomes.

Authors:  Michael O Dorschner; Laura M Amendola; Emily H Turner; Peggy D Robertson; Brian H Shirts; Carlos J Gallego; Robin L Bennett; Kelly L Jones; Mari J Tokita; James T Bennett; Jerry H Kim; Elisabeth A Rosenthal; Daniel S Kim; Holly K Tabor; Michael J Bamshad; Arno G Motulsky; C Ronald Scott; Colin C Pritchard; Tom Walsh; Wylie Burke; Wendy H Raskind; Peter Byers; Fuki M Hisama; Deborah A Nickerson; Gail P Jarvik
Journal:  Am J Hum Genet       Date:  2013-09-19       Impact factor: 11.025

4.  Return of genomic results to research participants: the floor, the ceiling, and the choices in between.

Authors:  Gail P Jarvik; Laura M Amendola; Jonathan S Berg; Kyle Brothers; Ellen W Clayton; Wendy Chung; Barbara J Evans; James P Evans; Stephanie M Fullerton; Carlos J Gallego; Nanibaa' A Garrison; Stacy W Gray; Ingrid A Holm; Iftikhar J Kullo; Lisa Soleymani Lehmann; Cathy McCarty; Cynthia A Prows; Heidi L Rehm; Richard R Sharp; Joseph Salama; Saskia Sanderson; Sara L Van Driest; Marc S Williams; Susan M Wolf; Wendy A Wolf; Wylie Burke
Journal:  Am J Hum Genet       Date:  2014-05-08       Impact factor: 11.025

5.  Managing incidental findings and research results in genomic research involving biobanks and archived data sets.

Authors:  Susan M Wolf; Brittney N Crock; Brian Van Ness; Frances Lawrenz; Jeffrey P Kahn; Laura M Beskow; Mildred K Cho; Michael F Christman; Robert C Green; Ralph Hall; Judy Illes; Moira Keane; Bartha M Knoppers; Barbara A Koenig; Isaac S Kohane; Bonnie Leroy; Karen J Maschke; William McGeveran; Pilar Ossorio; Lisa S Parker; Gloria M Petersen; Henry S Richardson; Joan A Scott; Sharon F Terry; Benjamin S Wilfond; Wendy A Wolf
Journal:  Genet Med       Date:  2012-04       Impact factor: 8.822

6.  Population studies: return of research results and incidental findings Policy Statement.

Authors:  Bartha Maria Knoppers; Mylène Deschênes; Ma'n H Zawati; Anne Marie Tassé
Journal:  Eur J Hum Genet       Date:  2012-07-11       Impact factor: 4.246

7.  Genetic incidental findings: autonomy regained?

Authors:  Effy Vayena; John Tasioulas
Journal:  Genet Med       Date:  2013-08-01       Impact factor: 8.822

8.  Research participant interest in primary, secondary, and incidental genomic findings.

Authors:  Jennifer T Loud; Renee C Bremer; Phuong L Mai; June A Peters; Neelam Giri; Douglas R Stewart; Mark H Greene; Blanche P Alter; Sharon A Savage
Journal:  Genet Med       Date:  2016-04-21       Impact factor: 8.822

Review 9.  Future-proofing biobanks' governance.

Authors:  Felix Gille; Effy Vayena; Alessandro Blasimme
Journal:  Eur J Hum Genet       Date:  2020-05-18       Impact factor: 4.246

10.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Authors:  Robert C Green; Jonathan S Berg; Wayne W Grody; Sarah S Kalia; Bruce R Korf; Christa L Martin; Amy L McGuire; Robert L Nussbaum; Julianne M O'Daniel; Kelly E Ormond; Heidi L Rehm; Michael S Watson; Marc S Williams; Leslie G Biesecker
Journal:  Genet Med       Date:  2013-06-20       Impact factor: 8.822

View more
  1 in total

1.  Public preferences towards data management and governance in Swiss biobanks: results from a nationwide survey.

Authors:  Caroline Brall; Claudia Berlin; Marcel Zwahlen; Effy Vayena; Matthias Egger; Kelly E Ormond
Journal:  BMJ Open       Date:  2022-08-26       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.